Iovance Biotherapeutics Inc (IOVA)
10.35
+0.03
(+0.29%)
USD |
NASDAQ |
May 22, 16:00
10.44
+0.09
(+0.87%)
After-Hours: 20:00
Iovance Biotherapeutics Cash from Investing (TTM): -420.14M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -420.14M |
| December 31, 2023 | -155.24M |
| September 30, 2023 | -81.94M |
| June 30, 2023 | 70.79M |
| March 31, 2023 | 323.34M |
| December 31, 2022 | 256.46M |
| September 30, 2022 | 325.33M |
| June 30, 2022 | 264.36M |
| March 31, 2022 | 9.437M |
| December 31, 2021 | 0.132M |
| September 30, 2021 | -10.45M |
| June 30, 2021 | -76.16M |
| March 31, 2021 | -340.75M |
| December 31, 2020 | -317.85M |
| September 30, 2020 | -349.79M |
| June 30, 2020 | -293.34M |
| March 31, 2020 | 189.10M |
| December 31, 2019 | 90.02M |
| September 30, 2019 | -143.17M |
| June 30, 2019 | -296.04M |
| March 31, 2019 | -385.22M |
| December 31, 2018 | -386.28M |
| September 30, 2018 | -179.84M |
| June 30, 2018 | -15.98M |
| March 31, 2018 | 39.85M |
| Date | Value |
|---|---|
| December 31, 2017 | 58.68M |
| September 30, 2017 | 84.38M |
| June 30, 2017 | 53.54M |
| March 31, 2017 | 17.82M |
| December 31, 2016 | 8.894M |
| September 30, 2016 | -7.751M |
| June 30, 2016 | 28.95M |
| March 31, 2016 | -60.55M |
| December 31, 2015 | -71.21M |
| September 30, 2015 | -81.75M |
| June 30, 2015 | -102.26M |
| March 31, 2015 | -2.371M |
| December 31, 2014 | -1.592M |
| September 30, 2014 | -0.1673M |
| June 30, 2014 | -0.0187M |
| March 31, 2014 | -0.0164M |
| December 31, 2013 | -0.013M |
| September 30, 2013 | -0.0127M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.0607M |
| June 30, 2012 | -0.0142M |
| March 31, 2012 | -0.0311M |
| December 31, 2011 | -0.0811M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-420.14M
Minimum
Mar 2024
325.33M
Maximum
Sep 2022
-47.80M
Average
-43.30M
Median
Cash from Investing (TTM) Benchmarks
| Viatris Inc | -168.90M |
| Perspective Therapeutics Inc | -48.19M |
| Electromed Inc | -0.79M |
| Xtant Medical Holdings Inc | -8.037M |
| Asensus Surgical Inc | 37.77M |